Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) significantly reduces the rate of relapse in acute myeloid leukemia (AML) but comes at the cost of significant treatment-related mortality. Despite the reduction in relapse overall, it remains common, especially in high-risk groups. The...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood advances 2020-04, Vol.4 (7), p.1206-1216
Hauptverfasser:	Abadir, Edward, Silveira, Pablo A., Gasiorowski, Robin E., Ramesh, Murari, Romano, Adelina, Mekkawy, Ahmed H., Lo, Tsun-Ho, Kabani, Karieshma, Sutherland, Sarah, Pietersz, Geoffrey A., Ho, P. Joy, Bryant, Christian E., Larsen, Stephen R., Clark, Georgina J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Hematopoietic Stem Cell Transplantation Humans Leukemia, Myeloid, Acute - therapy Mice Myeloid Neoplasia Retrospective Studies Transplantation Conditioning Transplantation, Homologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!